Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity.

Respiratory investigation·2024
Same author

Publisher Correction: Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance.

Nature genetics·2024
Same author

Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance.

Nature genetics·2024
Same author

Network-Constrained Eigen-Single-Cell Profile Estimation for Uncovering Crucial Immunogene Regulatory Systems in Human Bone Marrow.

Journal of computational biology : a journal of computational molecular cell biology·2024
Same author

Meta graphical lasso: uncovering hidden interactions among latent mechanisms.

Scientific reports·2024
Same author

Sparse spectral graph analysis and its application to gastric cancer drug resistance-specific molecular interplays identification.

PloS one·2024

Related Experiment Video

Updated: May 21, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Statistical model-based testing to evaluate the recurrence of genomic aberrations.

Atushi Niida1, Seiya Imoto, Teppei Shimamura

  • 1Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. aniida@ims.u-tokyo.ac.jp

Bioinformatics (Oxford, England)
|June 13, 2012
PubMed
Summary

We developed a new method, Parametric Aberration Recurrence Test (PART), to identify cancer genes by detecting recurrent genomic aberrations. PART-up analyzes unpaired data, crucial for cancer genome screening.

More Related Videos

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Related Experiment Videos

Last Updated: May 21, 2026

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Cancer genomes frequently exhibit genomic aberrations in cancer gene regions.
  • Identifying recurrent genomic aberrations is key for cancer gene screening.
  • Existing methods struggle with unpaired genomic data, leading to false discoveries.

Purpose of the Study:

  • To develop a novel statistical method for detecting recurrent genomic aberrations.
  • To address the challenge of analyzing unpaired genomic data in cancer research.
  • To provide a robust framework for identifying driver aberrations in cancer genomes.

Main Methods:

  • Introduced the Parametric Aberration Recurrence Test (PART) using Poisson-binomial statistics for efficient P-value computation.
  • Extended PART to PART-up for analyzing unpaired genomic data by removing pseudo-aberrations.
  • Applied PART-up to predict recurrent genomic aberrations in cancer cell lines lacking paired normal samples.

Main Results:

  • PART offers more efficient and precise P-value calculation compared to permutation-based methods.
  • PART-up successfully identifies recurrent genomic aberrations in unpaired cancer genomic datasets.
  • Demonstrated the utility of PART-up in predicting aberrations where paired normal controls are unavailable.

Conclusions:

  • PART and PART-up provide a powerful statistical framework for identifying driver aberrations.
  • These methods are applicable to the growing volume of next-generation sequencing cancer genomic data.
  • The developed tools are available for public use, facilitating further cancer research.